RadNet (RDNT) Bank of America Securities 2024 Leveraged Finance Conference summary

Business overview and growth strategy

• Operates 399 diagnostic imaging centers, primarily in eight states, with over 38% in joint ventures with health systems.

• Revenue for 2024 projected at $1.8 billion with $280 million EBITDA, growing over 10% annually.

• Focuses on geographic density for cost efficiency and negotiating leverage with insurers.

• Advanced imaging, though only 26% of volume, generates about 60% of revenue and is growing as a share.

• Plans to expand through de novo centers and selective acquisitions, with 15 new centers planned for 2025.

Industry trends and market dynamics

• U.S. diagnostic imaging is a $100 billion+ industry, growing in the low single digits annually.

• Market share is shifting from hospitals to outpatient centers, driven by insurer incentives and patient demand.

• Patient backlogs are increasing due to insufficient growth in the number of centers.

• PET/CT is the fastest-growing modality, driven by advances in prostate and Alzheimer's imaging.

• Medicare reimbursement is stable, with a minor 2.8% cut expected but likely to be reversed.

Digital health and AI initiatives

• Digital Health segment, including AI and IT solutions, is growing over 30% year-over-year.

• Launched DeepHealth OS, a cloud-based operating system, and announced OEM partnerships with GE and Siemens.

• AI-powered Enhanced Breast Cancer Detection (EBCD) program offers earlier cancer detection, with up to 40% adoption on the East Coast.

• AI solutions are used for triage and workflow, but radiologist sign-off remains required.

• Owns and uses de-identified patient data to train algorithms, with legal confidence in data ownership.